Aethlon Medical (AEMD) Net Income towards Common Stockholders Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.34% |
| Sep 30, 2025 | 3.14% |
| Jun 30, 2025 | -4.47% |
| Mar 31, 2025 | -1.36% |
| Dec 31, 2024 | -16.41% |
| Sep 30, 2024 | -10.46% |
| Jun 30, 2024 | -4.46% |
| Mar 31, 2024 | -7.89% |
| Dec 31, 2023 | -11.41% |
| Sep 30, 2023 | -16.70% |
| Jun 30, 2023 | -23.29% |
| Mar 31, 2023 | -13.22% |
| Dec 31, 2022 | -18.50% |
| Sep 30, 2022 | -24.01% |
| Jun 30, 2022 | -9.22% |
| Mar 31, 2022 | -17.46% |
| Dec 31, 2021 | -14.70% |
| Sep 30, 2021 | 2.36% |
| Jun 30, 2021 | -12.32% |
| Mar 31, 2021 | -12.49% |
| Dec 31, 2020 | -14.67% |
| Sep 30, 2020 | -7.19% |
| Jun 30, 2020 | -3.01% |
| Mar 31, 2020 | -6.69% |
| Dec 31, 2019 | 7.85% |
| Sep 30, 2019 | -20.23% |
| Jun 30, 2019 | -10.57% |
| Mar 31, 2019 | 1.41% |
| Dec 31, 2018 | -8.45% |
| Sep 30, 2018 | -32.74% |
| Jun 30, 2018 | -5.31% |
| Mar 31, 2018 | -12.54% |
| Dec 31, 2017 | -8.00% |
| Sep 30, 2017 | -17.67% |
| Jun 30, 2017 | -34.88% |
| Mar 31, 2017 | -34.57% |
| Dec 31, 2016 | -107.59% |
| Sep 30, 2016 | -51.59% |
| Jun 30, 2016 | -30.60% |
| Mar 31, 2016 | 3.97% |
| Dec 31, 2015 | 5.49% |
| Sep 30, 2015 | 18.90% |
| Jun 30, 2015 | 6.94% |